YM’s Direct Offering Raises $40M For Drug Development

Replidyne Gets $50M Up Front Through Forest Collaboration

Replidyne Gets $50M Up Front Through Forest Collaboration

After First Product Approval, BioMimetic Seeks $50M IPO

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

After First Product Approval, BioMimetic Seeks $50M IPO

Inflabloc Adds Cancer Drugs Through Merger, Raises $6M

Inflabloc Adds Cancer Drugs Through Merger, Raises $6M

Immtech Prices $16M Public Offering; EpiCept Adds $11M